Grunin Michelle, Tiosano Liran, Jaouni Tareq, Averbukh Edward, Sharon Dror, Chowers Itay
a Department of Ophthalmology , Hadassah-Hebrew University Medical Center , Jerusalem , Israel.
Ophthalmic Genet. 2016 Sep;37(3):285-9. doi: 10.3109/13816810.2015.1059456. Epub 2016 Feb 5.
A minority of patients with adult-onset foveomacular vitelliform dystrophy (AFVD) carry mutations in the PRPH2 gene. This gene is highly polymorphic and it was suggested that single-nucleotide polymorphisms (SNPs) in PRPH2 may also be associated with AFVD. We aimed to evaluate for such an association.
A single center cohort from a tertiary referral center including 52 consecutive patients with a clinical diagnosis of AFVD and 91 unaffected individuals was assessed. Sanger sequencing was performed for the PRPH2, BEST1, and IMPG1/2 genes. Investigation as to the frequency of minor alleles for SNPs in PRPH2 was performed and compared to HapMap and Exome Variant Server (EVS) data.
None of the patients carry a mutation in PRPH2, BEST1, or IMPG1/2. Five of 14 known SNPs (rs835, rs361524, rs434102, rs425876, rs390659) in exon 3 of PRPH2 were identified in AFVD patients. A high frequency and percentage of minor alleles of these five SNPs was found in the Israeli AFVD patients and controls compared with European, Chinese, Japanese and African populations identified via HapMap and EVS (p < 0.05). Power calculation suggested that the sample size was sufficient (80%) to rule out an association with an odds ratio above 2.5.
These results suggest that genetic variants in PRPH2 do not compose a major genetic risk factor for AFVD. The Israeli population shows a higher percentage of minor allele frequencies in SNPs in the PRPH2 gene, as compared with other populations. This emphasizes the need for appropriate genetic background when performing SNP association testing.
少数成年起病的黄斑中心凹卵黄样营养不良(AFVD)患者携带PRPH2基因突变。该基因具有高度多态性,有人提出PRPH2基因中的单核苷酸多态性(SNP)也可能与AFVD有关。我们旨在评估这种关联。
对来自三级转诊中心的单中心队列进行评估,该队列包括52例临床诊断为AFVD的连续患者和91例未受影响的个体。对PRPH2、BEST1和IMPG1/2基因进行桑格测序。对PRPH2基因中SNP的次要等位基因频率进行调查,并与HapMap和外显子变异服务器(EVS)数据进行比较。
所有患者均未携带PRPH2、BEST1或IMPG1/2基因突变。在AFVD患者中鉴定出PRPH2基因第3外显子中14个已知SNP中的5个(rs835、rs361524、rs434102、rs425876、rs390659)。与通过HapMap和EVS鉴定的欧洲、中国、日本和非洲人群相比,以色列AFVD患者和对照中这5个SNP的次要等位基因频率较高且百分比也较高(p<0.05)。功效计算表明样本量足以(80%)排除与比值比高于2.5的关联。
这些结果表明PRPH2基因中的遗传变异不是AFVD的主要遗传危险因素。与其他人群相比,以色列人群中PRPH2基因SNP的次要等位基因频率百分比更高。这强调了在进行SNP关联测试时需要适当的遗传背景。